ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Differentiated thyroid cancer: Monitoring during the first year after thyroid surgery

Differentiated thyroid cancer: Monitoring during the first year after thyroid surgery
  Risk of recurrence
Low Intermediate High
Nonstimulated Tg*

4 to 6 weeks

3 to 6 months

9 to 12 months

4 to 6 weeks

3 to 6 months

9 to 12 months

4 to 6 weeks

3 to 6 months

9 to 12 months
Neck ultrasound At 6 to 12 months At 6 to 12 months Every 6 to 12 months
Diagnostic WBS Usually not indicated Case specific Case specific
MRI, CT Not indicated Not indicated If Tg elevated or high clinical suspicion
FDG-PET Not indicated Not indicated If Tg >10 ng/mL
Serum TSH goal

0.1 to 0.5 mU/L if nonstimulated Tg detectable

0.5 to 2.0 mU/L if nonstimulated Tg undetectable
0.1 to 0.5 mU/L <0.1 mU/L

Tg: thyroglobulin; WBS: whole-body scan; MRI: magnetic resonance imaging; CT: computed tomography; FDG-PET: fludeoxyglucose-positron emission tomography; TSH: thyroid-stimulating hormone.

* Stimulated Tg may be required to document excellent response to therapy unless the functional sensitivity of the Tg assay is <0.2 ng/mL.
Data from: Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2016; 26:1.
Graphic 90173 Version 6.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟